Thrombosis and Anticoagulation Therapy in Patients with COVID-19 in Japan Study

Conditions

Coronavirus disease 2019: COVID-19, severe acute respiratory syndrome coronavirus 2: SARS-CoV-2, Thrombosis

Sen Yachi, Makoto Takeyama, Yuji Nishimoto, Ichizo Tsujino, Junichi Nakamura et al. (24 authors)

Annals of Vascular Diseases2023-01-123 citations

10.3400/avd.oa.22-00071

The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study.

Nishimoto Y, Yachi S, Takeyama M, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M, Yamashita Y, CLOT-COVID Study Investigators.

2022-04-0515 citations

10.1016/j.jjcc.2022.03.015

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were admitted to the hospital during the study period

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Occurrence of thrombosis during the hospitalization	—

Countries

Japan

Contacts

Public ContactYugo Yamashita

Kyoto University Hospital Department of Cardiovascular Medicine

yyamashi@kuhp.kyoto-u.ac.jp075-751-4254

Outcome results